Why the study?
Does an enhanced neutralization test using anti-immunoglobulin improve the detection of rubella antibodies compared to conventional tests?
Does an enhanced neutralization test using anti-immunoglobulin improve the detection of rubella antibodies compared to conventional tests?
The enhanced rubella neutralization test is highly sensitive and particularly useful for monitoring low-level antibody in cerebrospinal fluid.
Answers are grounded in this paper and cite their sources.
May aid low-level rubella antibody monitoring in CSF; leaves open need for clinical validation before routine use.
A modified rubella virus plaque neutralization test for measuring rubella antibody was developed based on the potentiation of the virus-antibody complex by heterologous anti-immunoglobulin. The test is highly sensitive, yielding titers on the average 50 to 100 times higher than the haemagglutination inhibition test or the conventional plaque neutralization test. The sensitivity of this enhanced neutralization test is somewhat limited by the existence of a prozone phenomenon which precludes testing of low-titered sera below a dilution of 1:16. No prozone effect was observed with cerebrospinal fluids. The specificity of the enhanced neutralization test was determined by seroconversion of individuals receiving rubella vaccine. Although the rubella hemagglutination inhibition test remains the test of choice in routine diagnostic and surveillance work, the enhanced rubella neutralization test is particularly useful in monitoring low-level antibody in the cerebrospinal fluid in patients with neurological disorders and in certain instances of vaccine failure.
No takes yet. Share an insight, caveat, or question.
Sato et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: